Loss per share

3 Months Ended

Mar. 31, 2023

Loss per shareFor periods in which the Company reports a net loss attributable to common stockholders, potentially dilutive securities have been excluded from the computation of diluted net loss per share as their effects would be anti-dilutive. Therefore, the

weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. For purposes of the dilutive net loss per share calculation, stock options, and restricted stock units for which the performance or market vesting conditions have been met are considered to be common stock equivalents, while restricted stock units with performance or market vesting conditions that were not met as of March 31, 2023 are not considered to be common stock equivalents. The Company excluded the following potential common shares presented based on amounts outstanding at period end from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:


	As of March 31,
	2023	2022
Anti-dilutive common stock equivalents:
Options to purchase common stock	8,464,159	7,321,491

Total anti-dilutive common stock equivalents	8,464,159	7,321,491

Basic and diluted loss per share is computed by dividing net loss by the weighted-average common shares outstanding for the three months ended March 31, 2023 and 2022 (in thousands, except share and per share data):


	Three Months Ended March 31,
		2023		2022
Numerator:
Net loss		$	(34,780)	$	(31,620)
Denominator:
Weighted-average number of shares used in computed net loss per share − basic and diluted		49,032,319		48,734,827
Net loss per share − basic and diluted		$	(0.71)	$	(0.65)